Onconic Therapeutics announced on September 29 that it has received approval from the Ministry of Food and Drug Safety for a Phase 2 clinical trial ...
The drug leucovorin was thrust into the national spotlight by President Donald Trump in a rambling press conference about ...
The Chosun Ilbo on MSN
Boryung boosts penicillin output, advances K-generic anticancer drugs
Boryung Co., Ltd. (CEO Kim Jeong-gyun) is focusing on stably producing and supplying essential medicines necessary for public ...
For patients with high-risk HER2-positive early breast cancer who have undergone neoadjuvant therapy, treatment with Enhertu ...
Idience, a subsidiary of Ildong Pharmaceutical focused on developing anticancer new drugs, announced on the 8th that it has entered into licensing agreements with partners in the Eurasian Economic ...
Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...
Arguably the most well-known SERD is AstraZeneca’s Faslodex, which was approved in 2002 for breast cancer and is administered ...
Cancer immunotherapies, anti-cancer treatments that target a patient’s own immune system, working to make it more effective, have revolutionized the | Cancer ...
Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies ...
Richmond firefighter Jonathan Clarke is suing major chemical companies, alleging PFAS in his turnout gear caused leukemia.
(Yicai) Sept. 25 -- Shares of Hengrui Pharmaceuticals rose after the Chinese drugmaker agreed to license a class I cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback